Fund Holdings — Frazier Life Sciences Management, L.P.

Total Portfolio Value:
$3.34B
Total Bought:
$422.10M
Total Sold:
$178.39M
Net Transaction:
+$243.71M
Notable People:
James Newman Topper, Patrick James Heron, Daniel Estes, James Brush, Albert (Nmn) Cha, Frazier Life Sciences Management,
Securities
▲▼
SharesValue
Q2 2025
▲▼
Q3 2025
▲▼
Change
▲▼
Q2 2025
▲▼
Q3 2025
▲▼
Weight (%)
▲▼
Change
▲▼
Mirum Pharmaceuticals, Inc.(MIRM)6,795,1216,795,1210$345.80M$498.15M14.93%+$152.35M
Newamsterdam Pharma Company
ORDINARY SHARES
16,607,07416,701,956+94,882$300.75M$475.00M14.23%+$174.25M
Verona Pharma PlcADS3,383,9503,383,9500$320.05M$361.10M10.82%+$41.05M
BridgeBio Pharma, Inc.(BBIO)3,800,4573,845,457+45,000$164.10M$199.73M5.98%+$35.63M
Arcutis Biotherapeutics, Inc.(ARQT)9,874,5119,874,5110$138.44M$186.13M5.58%+$47.69M
Phathom Pharmaceuticals, Inc.(PHAT)12,466,48912,466,4890$119.55M$146.73M4.40%+$27.18M
Krystal Biotech, Inc.(KRYS)688,460688,4600$94.64M$121.53M3.64%+$26.90M
Maze Therapeutics, Inc.(MAZE)4,567,2754,567,274-1$56.04M$118.43M3.55%+$62.39M
MBX Biosciences, Inc.(MBX)5,985,3476,652,013+666,666$68.29M$116.41M3.49%+$48.12M
Disc Medicine, Inc.(IRON)1,654,8341,438,534-216,300$87.64M$95.06M2.85%+$7.42M
Trevi Therapeutics, Inc.(TRVI)10,259,40910,259,4090$56.12M$93.87M2.81%+$37.75M
Tarsus Pharmaceuticals, Inc.(TARS)1,397,5271,167,527-230,000$56.61M$69.39M2.08%+$12.77M
Kalvista Pharmaceuticals Inc4,887,8675,039,867+152,000$55.26M$61.39M1.84%+$6.13M
Zai Lab LimitedADR(ZLAB)1,308,1381,627,320+319,182$45.75M$55.15M1.65%+$9.40M
Agios Pharmaceuticals, Inc.(AGIO)1,279,7541,279,7540$42.56M$51.37M1.54%+$8.80M
Erasca, Inc.(ERAS)22,729,43622,729,4360$28.87M$49.55M1.48%+$20.68M
Cytokinetics, Incorporated(CYTK)554,731890,445+335,714$18.33M$48.94M1.47%+$30.61M
Revolution Medicines, Inc.(RVMD)997,455997,4550$36.70M$46.58M1.40%+$9.88M
Palvella Therapeutics, Inc.(PVLA)722,400722,4000$16.28M$45.29M1.36%+$29.00M
Savara Inc.(SVRA)11,462,30111,462,3010$26.13M$40.92M1.23%+$14.79M
Dyne Therapeutics, Inc.(DYN)1,505,9842,718,105+1,212,121$14.34M$34.38M1.03%+$20.05M
ABIVAX Société AnonymeADS(ABVX)0378,300+378,300$0$32.12M0.96%+$32.12M
Aura Biosciences, Inc.(AURA)5,100,0005,100,0000$31.93M$31.52M0.94%-$408.0K
Ultragenyx Pharmaceutical Inc.(RARE)983,715983,7150$35.77M$29.59M0.89%-$6.18M
Lexeo Therapeutics, Inc.(LXEO)4,424,7254,424,7250$17.79M$29.38M0.88%+$11.59M
Valneva SEADS(VALN)1,458,3332,291,666+833,333$8.24M$27.96M0.84%+$19.72M
Avidity Biosciences Inc625,000625,0000$17.75M$27.23M0.82%+$9.48M
Ascendis Pharma A/SADR(ASND)133,333133,3330$23.01M$26.51M0.79%+$3.49M
Alkermes plcSHS(ALKS)1,000,647700,647-300,000$28.63M$21.02M0.63%-$7.61M
Mereo BioPharma Group plcADS(MREO)9,440,1129,440,1120$25.58M$19.45M0.58%-$6.14M
Akero Therapeutics Inc366,784366,7840$19.57M$17.41M0.52%-$2.16M
Vaxcyte, Inc.(PCVX)474,405474,4050$15.42M$17.09M0.51%+$1.67M
Evolus, Inc.(EOLS)2,435,5502,630,665+195,115$22.43M$16.15M0.48%-$6.28M
Design Therapeutics, Inc.(DSGN)1,953,5471,953,5470$6.58M$14.71M0.44%+$8.13M
Immunocore Holdings plcADS(IMCR)384,782384,7820$12.07M$13.98M0.42%+$1.90M
Acadia Pharmaceuticals Inc0613,837+613,837$0$13.10M0.39%+$13.10M
Jade Biosciences Inc1,772,1161,413,280-358,836$17.70M$12.20M0.37%-$5.51M
Assembly Biosciences Inc0456,249+456,249$0$11.68M0.35%+$11.68M
Adverum Biotechnologies Inc1,069,2442,077,431+1,008,187$2.30M$9.41M0.28%+$7.11M
Travere Therapeutics, Inc.(TVTX)1,002,092392,092-610,000$14.83M$9.37M0.28%-$5.46M
Newamsterdam Pharma CompanyW EXP 99 99 999
*W EXP 99/99/999
500,333500,3330$4.00M$8.56M0.26%+$4.56M
Engene Holdings Inc
COM
01,157,380+1,157,380$0$7.90M0.24%+$7.90M
Autolus Therapeutics plcADS(AUTL)4,623,3244,623,3240$10.54M$7.54M0.23%-$3.01M
MacroGenics, Inc.(MGNX)3,175,6653,175,6650$3.84M$5.34M0.16%+$1.49M
Silence Therapeutics plcADS(SLN)970,130970,1300$5.63M$5.03M0.15%-$591.8K
Allogene Therapeutics Inc3,868,7503,868,7500$4.37M$4.80M0.14%+$425.6K
Crescent Biopharma, Inc.(CBIO)453,685272,951-180,734$7.32M$3.25M0.10%-$4.08M
CG Oncology, Inc.(CGON)770,0000-770,000$20.02M$0—-$20.02M
Cogent Biosciences, Inc.(COGT)1,734,6010-1,734,601$12.45M$0—-$12.45M
Elevation Oncology Inc5,993,5790-5,993,579$2.20M$0—-$2.20M
Hillevax Inc10,617,0620-10,617,062$21.13M$0—-$21.13M
ORIC Pharmaceuticals, Inc.(ORIC)1,065,3340-1,065,334$10.81M$0—-$10.81M
Oruka Therapeutics, Inc.(ORKA)583,3270-583,327$6.54M$0—-$6.54M
Page 1 of 1
Frazier Life Sciences Management, L.P. — 13F Holdings — Q3 2025 | TickerTrail